Short-term survival benefit has not been demonstrated in adult GM-CSF studies; however, our evolving understanding of sepsis toward a model consistent with PICS demands an evaluation of more clinically relevant long-term endpoints such as long-term survival, discharge placement, and return to functional life rather than 28-day mortality. Here, CSF2 is linked to Sepsis.